Position in INSM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,020,567
+$551,849 QoQ
Shares Held
42,934
+15.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $475,548,112 across 32 Biotechnology names. INSM ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
554,024 | $247,393,876 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125,673 | $97,099,986 | |
| 3 | TECH |
BIO-TECHNE Corp
|
648,034 | $33,866,256 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
78,016 | $25,813,153 | |
| 5 | ARGX |
Argenx SE
|
20,380 | $14,882,495 | |
| 6 | INSM |
INSMED Inc
This page
|
42,934 | $7,020,567 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
106,305 | $6,870,492 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
26,729 | $5,053,117 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,020,567 | 42,934 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,468,718 | 37,168 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $5,681,194 | 39,450 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,568,593 | 35,459 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,278,171 | 29,862 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,472,278 | 21,325 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $1,525,262 | 20,894 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||